Assertio Holdings Future Growth
Future criteria checks 0/6
Assertio Holdings's revenue is forecast to decline at 4.5% per annum while its annual earnings are expected to grow at 155.2% per year. EPS is expected to grow by 156.3% per annum.
Key information
155.2%
Earnings growth rate
156.3%
EPS growth rate
Pharmaceuticals earnings growth | 24.1% |
Revenue growth rate | -4.5% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 07 May 2024 |
Recent future growth updates
Recent updates
Assertio Holdings, Inc. (NASDAQ:ASRT) Stock Catapults 29% Though Its Price And Business Still Lag The Industry
May 07Does Assertio Holdings (NASDAQ:ASRT) Have A Healthy Balance Sheet?
Apr 18Improved Revenues Required Before Assertio Holdings, Inc. (NASDAQ:ASRT) Stock's 26% Jump Looks Justified
Mar 13We Think Assertio Holdings (NASDAQ:ASRT) Can Stay On Top Of Its Debt
Apr 26Is There An Opportunity With Assertio Holdings, Inc.'s (NASDAQ:ASRT) 23% Undervaluation?
Mar 02Assertio Holdings Looks Good To Rebound After Recent Price Plunge
Sep 07Assertio Holdings: Substantial Upside
Aug 21Assertio Therapeutics Q2 2022 Earnings Preview
Aug 05Assertio Holdings: Management Still Swimming Against The Tide
Jun 10Assertio's Phenomenal Turnaround
May 19Assertio Holdings: Recent Breakout To Lead To Sustained Gains
Apr 07Assertio's Digital Strategy Looks To Be Paying Off
Jan 21Assertio shares rise on Q1 revenue strength, provides FY forecast
May 07Assertio announces restructuring plan and leadership change
Dec 15Assertio Therapeutics EPS misses by $0.05, beats on revenue
Nov 06Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 130 | 2 | 31 | 33 | 2 |
12/31/2024 | 120 | -17 | 15 | 17 | 2 |
3/31/2024 | 142 | -333 | 33 | 34 | N/A |
12/31/2023 | 152 | -332 | 49 | 50 | N/A |
9/30/2023 | 169 | -186 | 44 | 71 | N/A |
6/30/2023 | 168 | 98 | 51 | 78 | N/A |
3/31/2023 | 162 | 97 | 32 | 74 | N/A |
12/31/2022 | 156 | 110 | 36 | 79 | N/A |
9/30/2022 | 139 | 26 | 21 | 56 | N/A |
6/30/2022 | 130 | 25 | 16 | 51 | N/A |
3/31/2022 | 121 | 3 | 18 | 37 | N/A |
12/31/2021 | 111 | -1 | -13 | 6 | N/A |
9/30/2021 | 110 | -30 | -5 | -5 | N/A |
6/30/2021 | 119 | -44 | -24 | -24 | N/A |
3/31/2021 | 114 | -65 | -44 | -45 | N/A |
12/31/2020 | 108 | -28 | 303 | -66 | N/A |
9/30/2020 | 135 | -196 | 317 | -52 | N/A |
6/30/2020 | 156 | -183 | 365 | -3 | N/A |
3/31/2020 | 192 | -162 | 405 | 38 | N/A |
12/31/2019 | 230 | -217 | 89 | 90 | N/A |
9/30/2019 | 157 | -49 | 95 | 98 | N/A |
6/30/2019 | 180 | -4 | 130 | 135 | N/A |
3/31/2019 | 186 | -11 | 121 | 127 | N/A |
12/31/2018 | 256 | 37 | 67 | 72 | N/A |
9/30/2018 | 364 | 28 | 80 | 84 | N/A |
6/30/2018 | 381 | -36 | 9 | 10 | N/A |
3/31/2018 | 419 | -42 | 19 | 19 | N/A |
12/31/2017 | 381 | -102 | N/A | 62 | N/A |
9/30/2017 | 410 | -114 | N/A | 76 | N/A |
6/30/2017 | 425 | -111 | N/A | 96 | N/A |
3/31/2017 | 442 | -95 | N/A | 103 | N/A |
12/31/2016 | 456 | -89 | N/A | 71 | N/A |
9/30/2016 | 443 | -75 | N/A | 88 | N/A |
6/30/2016 | 437 | -74 | N/A | 120 | N/A |
3/31/2016 | 415 | -85 | N/A | 130 | N/A |
12/31/2015 | 343 | -76 | N/A | 152 | N/A |
9/30/2015 | 426 | 50 | N/A | 89 | N/A |
6/30/2015 | 373 | 68 | N/A | 40 | N/A |
3/31/2015 | 346 | 102 | N/A | 7 | N/A |
12/31/2014 | 390 | 132 | N/A | -56 | N/A |
9/30/2014 | 236 | 79 | N/A | -60 | N/A |
6/30/2014 | 222 | 79 | N/A | -45 | N/A |
3/31/2014 | 185 | 67 | N/A | -51 | N/A |
12/31/2013 | 134 | 43 | N/A | 10 | N/A |
9/30/2013 | 120 | -2 | N/A | 5 | N/A |
6/30/2013 | 116 | -10 | N/A | -10 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ASRT is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ASRT is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ASRT is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ASRT's revenue is expected to decline over the next 3 years (-4.5% per year).
High Growth Revenue: ASRT's revenue is forecast to decline over the next 3 years (-4.5% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ASRT's Return on Equity is forecast to be high in 3 years time